Prognostic biomarkers in primary progressive multiple sclerosis : Validating and scrutinizing multimodal evoked potentials
Published inClinical neurophysiology, vol. 137, p. 152-158
Publication date2022-05
First online date2022-03-07
Abstract
Keywords
- Biomarker
- Clinical trial design
- Evoked Potentials
- Prognosis
- Progressive Multiple Sclerosis
- Quantitative EP Score
Affiliation entities
Funding
- Swiss Multiple Sclerosis Society
Citation (ISO format)
HARDMEIER, M et al. Prognostic biomarkers in primary progressive multiple sclerosis : Validating and scrutinizing multimodal evoked potentials. In: Clinical neurophysiology, 2022, vol. 137, p. 152–158. doi: 10.1016/j.clinph.2022.02.019
Main files (1)
Article (Published version)
Identifiers
- PID : unige:183688
- DOI : 10.1016/j.clinph.2022.02.019
- PMID : 35316624
Additional URL for this publicationhttps://www.sciencedirect.com/science/article/pii/S1388245722001894
Journal ISSN1388-2457
